TCG Crossover Management’s ADARx Pharmaceuticals ADRX Stock Holding History
Bought
Maintained
Sold
Other funds holding ADRX
SL
TCG Crossover Management's ADRX Position: Q3 2026 in Review
TCG Crossover Management opened a new position in ADARx Pharmaceuticals (ADRX) in Q3 2026: 4,116,452 shares worth $82.1M. The stake represents 2.32% of the portfolio and ranks #16 among its holdings.
62 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.
- TCG Crossover Management held 4,116,452 shares of ADARx Pharmaceuticals worth $82.1M as of Q3 2026.
- ADARx Pharmaceuticals was a new TCG Crossover Management position in Q3 2026.
- ADARx Pharmaceuticals made up 2.32% of TCG Crossover Management's portfolio in Q3 2026, its #16 holding.
- 62 funds tracked by Wall St. Rank held ADARx Pharmaceuticals as of Q3 2026.
Based on TCG Crossover Management's 13F filing for Q3 2026, filed 16 Nov 2026.